We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Requests More Information From Implant Company
FDA Requests More Information From Implant Company
April 8, 2005
The FDA has sent a letter to Santa Barbara-based Inamed requesting more information about the company’s Style 410 Bio-Dimensional Cohesive Gel Matrix breast implants before the FDA can complete its review of Inamed’s Style 410 premarket approval (PMA).